Neural ECM proteases in learning and synaptic plasticity

Progress in Brain Research

Volumn 214, Issue , 2014, Pages 135-157

  Tsilibary, Effie ^a   Tzinia, Athina ^a   Radenovic, Lidija ^b   Stamenkovic, Vera ^b   Lebitko, Tomasz ^c   Mucha, Mariusz ^d   Pawlak, Robert ^d   Frischknecht, Renato ^e   Kaczmarek, Leszek ^c  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^d UNIVERSITY OF EXETER   (United Kingdom)

^e LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

Author keywords

Addiction; Autism; Cognitive behavior; Extracellular matrix; Long term potentiation; Metalloproteinases; Schizophrenia; Thrombin; Trypsin

Indexed keywords

MATRIX METALLOPROTEINASE; NEUROPSIN; PROTEINASE; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BEHAVIOR; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; LEARNING; LONG TERM POTENTIATION; MEMORY; MENTAL DISEASE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 84922281679     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63486-3.00006-2     Document Type: Chapter

References (152)

1. Abdallah M.W., Pearce B.D., Larsen N., Greaves-Lord K., Norgaard-Pedersen B., Hougaard D.M., et al. Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study. Autism Res. 2012, 5:428-433.
2. Almonte A.G., Sweatt J.D. Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior. Brain Res. 2011, 1407:107-122.
3. Attwood B.K., Bourgognon J.M., Patel S., Mucha M., Schiavon E., Skrzypiec A.E., et al. Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 2011, 473:372-375.
4. Basham M.E., Seeds N.W. Plasminogen expression in the neonatal and adult mouse brain. J. Neurochem. 2001, 77:318-325.
5. Bennur S., Shankaranarayana Rao B.S., Pawlak R., Strickland S., McEwen B.S., Chattarji S. Stress-induced spine loss in the medial amygdala is mediated by tissue-plasminogen activator. Neuroscience 2007, 144:8-16.
6. Bilousova T.V., Dansie L., Ngo M., Aye J., Charles J.R., Ethell D.W., Ethell I.M. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J. Med. Genet. 2009, 46:94-102.
7. Bolliger M.F., Zurlinden A., Luscher D., Butikofer L., Shakhova O., Francolini M., et al. Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. J. Cell Sci. 2010, 123:3944-3955.
8. Bozdagi O., Nagy V., Kwei K.T., Huntley G.W. In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J. Neurophysiol. 2007, 98:334-344.
9. Brown T.E., Forquer M.R., Cocking D.L., Jansen H.T., Harding J.W., Sorg B.A. Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference. Learn. Mem. 2007, 14:214-223.
10. Brown T.E., Wilson A.R., Cocking D.L., Sorg B.A. Inhibition of matrix metalloproteinase activity disrupts reconsolidation but not consolidation of a fear memory. Neurobiol. Learn. Mem. 2009, 91:66-72.
11. Calabresi P., Napolitano M., Centonze D., Marfia G.A., Gubellini P., Teule M.A., et al. Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur. J. Neurosci. 2000, 12:1002-1012.
12. Cao W., Duan J., Wang X., Zhong X., Hu Z., Huang F., et al. Early enriched environment induces an increased conversion of proBDNF to BDNF in the adult rat's hippocampus. Behav. Brain Res. 2014, 265:76-83.
13. Chang S.H., Chiang S.Y., Chiu C.C., Tsai C.C., Tsai H.H., Huang C.Y., et al. Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia. Psychiatry Res. 2011, 187:341-346.
14. Chen Z.L., Yoshida S., Kato K., Momota Y., Suzuki J., Tanaka T., et al. Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J. Neurosci. 1995, 15:5088-5097.
15. Conant K., Wang Y., Szklarczyk A., Dudak A., Mattson M.P., Lim S.T. Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation. Neuroscience 2010, 166:508-521.
16. Corvetti L., Rossi F. Degradation of chondroitin sulfate proteoglycans induces sprouting of intact purkinje axons in the cerebellum of the adult rat. J. Neurosci. 2005, 25:7150-7158.
17. Domenici E., Willé D.R., Tozzi F., Prokopenko I., Miller S., McKeown A., et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One 2010, 5:e9166.
18. Dziembowska M., Milek J., Janusz A., Rejmak E., Romanowska E., Gorkiewicz T., et al. Activity-dependent local translation of matrix metalloproteinase-9. J. Neurosci. 2012, 32:14538-14547.
19. Dziembowska M., Pretto D.I., Janusz A., Kaczmarek L., Leigh M.J., Gabriel N., et al. High MMP-9 activity levels in fragile X syndrome are lowered by minocycline. Am. J. Med. Genet. A 2013, 161A:1897-1903.
20. Dzwonek J., Rylski M., Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 2004, 567:129-135.
21. Foscarin S., Ponchione D., Pajaj E., Leto K., Gawlak M., Wilczynski G.M., et al. Experience-dependent plasticity and modulation of growth regulatory molecules at central synapses. PLoS One 2011, 6:e16666.
22. Frey U., Muller M., Kuhl D. A different form of long-lasting potentiation revealed in tissue plasminogen activator mutant mice. J. Neurosci. 1996, 16:2057-2063.
23. Frischknecht R., Fejtova A., Viesti M., Stephan A., Sonderegger P. Activity-induced synaptic capture and exocytosis of the neuronal serine protease neurotrypsin. J. Neurosci. 2008, 28:1568-1579.
24. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 2007, 54:1-18.
25. Ganguly K., Rejmak E., Mikosz M., Nikolaev E., Knapska E., Kaczmarek L. Matrix metalloproteinase (MMP) 9 transcription in mouse brain induced by fear learning. J. Biol. Chem. 2013, 288:20978-20991.
26. Garvin P., Nilsson L., Carstensen J., Jonasson L., Kristenson M. Plasma levels of matrix metalloproteinase-9 are independently associated with psychosocial factors in a middle-aged normal population. Psychosom. Med. 2009, 71:292-300.
27. Gautam M., Noakes P.G., Moscoso L., Rupp F., Scheller R.H., Merlie J.P., Sanes J.R. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 1996, 85:525-535.
28. Gawlak M., Górkiewicz T., Gorlewicz A., Konopacki F.A., Kaczmarek L., Wilczynski G.M. High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses. Neuroscience 2009, 158:167-176.
29. Gisler C., Luscher D., Schatzle P., Durr S., Baici A., Galliciotti G., et al. Zymogen activation of neurotrypsin and neurotrypsin-dependent agrin cleavage on the cell surface are enhanced by glycosaminoglycans. Biochem. J. 2013, 453:83-100.
30. Glass D.J., Bowen D.C., Stitt T.N., Radziejewski C., Bruno J., Ryan T.E., et al. Agrin acts via a MuSK receptor complex. Cell 1996, 85:513-523.
31. Golgi C. Intorno all'origine del quarto nervo cerebrale e una questione isto-fisiologica che a questo argomento si collega. Rendiconti della Reale Accademia Del Lincei 1893, 2:433-450.
32. Gschwend T.P., Krueger S.R., Kozlov S.V., Wolfer D.P., Sonderegger P. Neurotrypsin, a novel multidomain serine protease expressed in the nervous system. Mol. Cell. Neurosci. 1997, 9:207-219.
33. Han H., He X., Tang J., Liu W., Liu K., Zhang J., et al. The C(-1562)T polymorphism of matrix metalloproteinase-9 gene is associated with schizophrenia in China. Psychiatry Res. 2011, 190:163-174.
34. Hilgenberg L.G., Smith M.A. Agrin signaling in cortical neurons is mediated by a tyrosine kinase-dependent increase in intracellular Ca2+ that engages both CaMKII and MAPK signal pathways. J. Neurobiol. 2004, 61:289-300.
35. Hilgenberg L.G., Su H., Gu H., O'Dowd D.K., Smith M.A. Alpha3Na+/K+-ATPase is a neuronal receptor for agrin. Cell 2006, 125:359-369.
36. Hirata A., Yoshida S., Inoue N., Matsumoto-Miyai K., Ninomiya A., Taniguchi M., et al. Abnormalities of synapses and neurons in the hippocampus of neuropsin-deficient mice. Mol. Cell. Neurosci. 2001, 17:600-610.
37. Hoirisch-Clapauch S., Nardi A.E. Multiple roles of tissue plasminogen activator in schizophrenia pathophysiology. Semin. Thromb. Hemost. 2013, 39:950-954.
38. Hoirisch-Clapauch S., Nardi A.E., Gris J.C., Brenner B. Mental disorders and thrombotic risk. Semin. Thromb. Hemost. 2013, 39:943-949.
39. Horii Y., Yamasaki N., Miyakawa T., Shiosaka S. Increased anxiety-like behavior in neuropsin (kallikrein-related peptidase 8) gene-deficient mice. Behav. Neurosci. 2008, 122:498-504.
40. Horii-Hayashi N., Yoshikawa M., Matsusue Y., Ishizaka S., Nishi M., Wanaka A. Environmental stimulation changes tissue-type plasminogen activator activity in the adult mouse hippocampus. Neurochem. Int. 2011, 58:1-4.
41. Huang Y.Y., Bach M.E., Lipp H.P., Zhuo M., Wolfer D.P., Hawkins R.D., et al. Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:8699-8704.
42. Iijima N., Tanaka M., Mitsui S., Yamamura Y., Yamaguchi N., Ibata Y. Expression of a serine protease (motopsin PRSS12) mRNA in the mouse brain: in situ hybridization histochemical study. Brain Res. Mol. Brain Res. 1999, 66:141-149.
43. Ishikawa Y., Horii Y., Tamura H., Shiosaka S. Neuropsin (KLK8)-dependent and -independent synaptic tagging in the Schaffer-collateral pathway of mouse hippocampus. J. Neurosci. 2008, 28:843-849.
44. Izumi A., Iijima Y., Noguchi H., Numakawa T., Okada T., Hori H., et al. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions. Neuropsychopharmacology 2008, 33:3237-3245.
45. Janusz A., Milek J., Perycz M., Pacini L., Bagni C., Kaczmarek L., et al. The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses. J. Neurosci. 2013, 33:18234-18241.
46. Jaworski J., Biedermann I.W., Lapinska J., Szklarczyk A., Figiel I., Konopka D., et al. Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus. J. Biol. Chem. 1999, 274:28106-28112.
47. Kaczmarek L., Lapinska-Dzwonek J., Szymczak S. Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?. EMBO J. 2002, 21:6643-6648.
48. Kaliszewska A., Bijata M., Kaczmarek L., Kossut M. Experience-dependent plasticity of the barrel cortex in mice observed with 2-DG brain mapping and c-Fos: effects of MMP-9 KO. Cereb. Cortex 2012, 22:2160-2170.
49. Karetko M., Skangiel-Kramska J. Diverse functions of perineuronal nets. Acta Neurobiol. Exp. (Wars) 2009, 69:564-577.
50. Kato K., Kishi T., Kamachi T., Akisada M., Oka T., Midorikawa R., et al. Serine proteinase inhibitor 3 and murinoglobulin I are potent inhibitors of neuropsin in adult mouse brain. J. Biol. Chem. 2001, 276:14562-14571.
51. Kelly E.A., Tremblay M.-E., Gahmberg C.G., Tian L., Majewska A.K. Subcellular localization of intercellular adhesion molecule-5 (telencephalin) in the visual cortex is not developmentally regulated in the absence of matrix metalloproteinase-9. J. Comp. Neurol. 2014, 522:676-688.
52. Kim N., Stiegler A.L., Cameron T.O., Hallock P.T., Gomez A.M., Huang J.H., et al. Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 2008, 135:334-342.
53. Knapska E., Walasek G., Nikolaev E., Neuhäusser-Wespy F., Lipp H.-P., Kaczmarek L., et al. Differential involvement of the central amygdala in appetitive versus aversive learning. Learn. Mem. 2006, 13:192-200.
54. Knapska E., Lioudyno V., Kiryk A., Mikosz M., Górkiewicz T., Michaluk P., et al. Reward learning requires activity of matrix metalloproteinase-9 in the central amygdala. J. Neurosci. 2013, 33:14591-14600.
55. Konopacki F.A., Rylski M., Wilczek E., Amborska R., Detka D., Kaczmarek L., et al. Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA. Neuroscience 2007, 150:31-39.
56. Konopka W., Kiryk A., Novak M., Herwerth M., Parkitna J.R., Wawrzyniak M., et al. MicroRNA loss enhances learning and memory in mice. J. Neurosci. 2010, 30:14835-14842.
57. Kovatsi L., Batzios S., Nikolaou K., Fragou D., Njau S., Tsatsakis A., et al. Alterations in serum MMP and TIMP concentrations following chronic heroin abuse. Toxicol. Mech. Methods 2013, 23:377-381.
58. Kumarasinghe N., Beveridge N.J., Gardiner E., Scott R.J., Yasawardene S., Perera A., et al. Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication. Int. J. Neuropsychopharmacol. 2013, 16:1483-1503.
59. Kuzniewska B., Rejmak E., Malik A.R., Jaworski J., Kaczmarek L., Kalita K. Brain-derived neurotrophic factor induces matrix metalloproteinase 9 expression in neurons via the serum response factor/c-Fos pathway. Mol. Cell. Biol. 2013, 33:2149-2162.
60. Kwok J.C., Carulli D., Fawcett J.W. In vitro modeling of perineuronal nets: hyaluronan synthase and link protein are necessary for their formation and integrity. J. Neurochem. 2010, 114:1447-1459.
61. Kwok J.C., Dick G., Wang D., Fawcett J.W. Extracellular matrix and perineuronal nets in CNS repair. Dev. Neurobiol. 2011, 71:1073-1089.
62. Leigh M.J., Nguyen D.V., Mu Y., Winarni T.I., Schneider A., Chechi T., et al. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. J. Dev. Behav. Pediatr. 2013, 34:147-155.
63. Lonskaya I., Partridge J., Lalchandani R.R., Chung A., Lee T., Vicini S., et al. Soluble ICAM-5, a product of activity dependent proteolysis, increases mEPSC frequency and dendritic expression of GluA1. PLoS One 2013, 8:e69136.
64. Lu P., Takai K., Weaver V.M., Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb. Persp. Biol. 2011, 3:1-24.
65. Madani R., Hulo S., Toni N., Madani H., Steimer T., Muller D., et al. Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO J. 1999, 18:3007-3012.
66. Mash D.C., ffrench-Mullen J., Adi N., Qin Y., Buck A., Pablo J. Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. PLoS One 2007, 2:e1187.
67. Massey J.M., Hubscher C.H., Wagoner M.R., Decker J.A., Amps J., Silver J., et al. Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J. Neurosci. 2006, 26:4406-4414.
68. Mataga N., Nagai N., Hensch T.K. Permissive proteolytic activity for visual cortical plasticity. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:7717-7721.
69. Matsumoto-Miyai K., Ninomiya A., Yamasaki H., Tamura H., Nakamura Y., Shiosaka S. NMDA-dependent proteolysis of presynaptic adhesion molecule L1 in the hippocampus by neuropsin. J. Neurosci. 2003, 23:7727-7736.
70. Matsumoto-Miyai K., Sokolowska E., Zurlinden A., Gee C.E., Luscher D., Hettwer S., et al. Coincident pre- and postsynaptic activation induces dendritic filopodia via neurotrypsin-dependent agrin cleavage. Cell 2009, 136:1161-1171.
71. Matys T., Strickland S. Tissue plasminogen activator and NMDA receptor cleavage. Nat. Med. 2003, 9:371-372.
72. Matys T., Pawlak R., Strickland S. Tissue plasminogen activator in the bed nucleus of stria terminalis regulates acoustic startle. Neuroscience 2005, 135:715-722.
73. Meighan S.E., Meighan P.C., Choudhury P., Davis C.J., Olson M.L., Zornes P.A., et al. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J. Neurochem. 2006, 96:1227-1241.
74. Meighan P.C., Meighan S.E., Davis C.J., Wright J.W., Harding J.W. Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses. J. Neurochem. 2007, 102:2085-2096.
75. Melchor J.P., Strickland S. Tissue plasminogen activator in central nervous system physiology and pathology. Thromb. Haemost. 2005, 93:655-660.
76. Michaluk P., Kaczmarek L. Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction. Cell Death Differ. 2007, 14:1255-1258.
77. Michaluk P., Mikasova L., Groc L., Frischknecht R., Choquet D., Kaczmarek L. Matrix Metalloproteinase-9 controls NMDA receptor surface diffusion through Integrin β1 signaling. J. Neurosci. 2009, 29:6007-6012.
78. Michaluk P., Wawrzyniak M., Alot P., Szczot M., Wyrembek P., Mercik K., et al. Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology. J. Cell Sci. 2011, 124:3369-3380.
79. Mikami T., Yasunaga D., Kitagawa H. Contactin-1 is a functional receptor for neuroregulatory chondroitin sulfate-E. J. Biol. Chem. 2009, 284:4494-4499.
80. Molinari F., Rio M., Meskenaite V., Encha-Razavi F., Augé J., Bacq D., et al. Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental retardation. Science 2002, 298:1779-1781.
81. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., et al. Matrix Metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J. Neurosci. 2006, 26:1923-1934.
82. Nagy V., Bozdagi O., Huntley G.W. The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory. Learn. Mem. 2007, 14:655-664.
83. Nedivi E., Hevroni D., Naot D., Israeli D., Citri Y. Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature 1993, 363:718-722.
84. Nicole O., Docagne F., Ali C., Margaill I., Carmeliet P., MacKenzie E.T., Vivien D., Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat. Med. 2001, 7:59-64.
85. Niedringhaus M., Chen X., Dzakpasu R., Conant K. MMPs and soluble ICAM-5 increase neuronal excitability within in vitro networks of hippocampal neurons. PLoS One 2012, 7:e42631.
86. Nithianantharajah J., Hannan A.J. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 2006, 7:697-709.
87. Norris E.H., Strickland S. Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13473-13478.
88. Ogata Y., Enghild J.J., Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 1992, 267:3581-3584.
89. Okulski P., Jay T.M., Jaworski J., Duniec K., Dzwonek J., Konopacki F.A., et al. TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol. Psychiatry 2007, 62:359-362.
90. Olson M.L., Meighan P.C., Brown T.E., Asay A.L., Benoist C.C., Harding J.W. Hippocampal MMP-3 elevation is associated with passive avoidance conditioning. Regul. Pept. 2008, 146:19-25.
91. Oray S., Majewska A., Sur M. Dendritic spine dynamics are regulated by monocular deprivation and extracellular matrix degradation. Neuron 2004, 44:1021-1030.
92. Pang P.T., Teng H.K., Zaitsev E., Woo N.T., Sakata K., Zhen S., et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004, 306:487-491.
93. Pawlak R., Nagai N., Urano T., Napiorkowska-Pawlak D., Ihara H., Takada Y., Collen D., Takada A. Rapid, specific and active site-catalyzed effect of tissue-plasminogen activator on hippocampus-dependent learning in mice. Neuroscience 2002, 113:995-1001.
94. Pawlak R., Magarinos A.M., Melchor J., McEwen B., Strickland S. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat. Neurosci. 2003, 6:168-174.
95. Pawlak R., Melchor J.P., Matys T., Skrzypiec A.E., Strickland S. Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:443-448.
96. Pawlak R., Rao B.S., Melchor J.P., Chattarji S., McEwen B., Strickland S. Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18201-18206.
97. Proba K., Gschwend T.P., Sonderegger P. Cloning and sequencing of the cDNA encoding human neurotrypsin. Biochim. Biophys. Acta 1998, 1396:143-147.
98. Qian Z., Gilbert M.E., Colicos M.A., Kandel E.R., Kuhl D. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 1993, 361:453-457.
99. Reif R., Sales S., Hettwer S., Dreier B., Gisler C., Wolfel J., et al. Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. FASEB J. 2007, 21:3468-3478.
100. Reif R., Sales S., Dreier B., Lüscher D., Wölfel J., Gisler C., et al. Purification and enzymological characterization of murine neurotrypsin. Protein Expr. Purif. 2008, 61:13-21.
101. Rhodes K.E., Fawcett J.W. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?. J. Anat. 2004, 204:33-48.
102. Rosenzweig M.R., Bennett E.L., Hebert M., Morimoto H. Social grouping cannot account for cerebral effects of enriched environments. Brain Res. 1978, 153:563-576.
103. Rybakowski J.K., Skibinska M., Kapelski P., Kaczmarek L., Hauser J. Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophr. Res. 2009, 109:90-93.
104. Rybakowski J.K., Skibinska M., Leszczynska-Rodziewicz A., Kaczmarek L., Hauser J. Matrix metalloproteinase-9 gene and bipolar mood disorder. Neuromol. Med. 2009, 11:128-132.
105. Rybakowski J.K., Skibinska M., Leszczynska-Rodziewicz A., Kaczmarek L., Hauser J. Matrix metalloproteinase-9 gene modulates prefrontal cognition in bipolar men. Psychiatr. Genet. 2009, 19:108-109.
106. Rybakowski J.K., Remlinger-Molenda A., Czech-Kucharska A., Wojcicka M., Michalak M., Losy J. Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression. J. Affect. Disord. 2013, 146:286-289.
107. Rylski M., Amborska R., Zybura K., Michaluk P., Bielinska B., Konopacki F.A., et al. JunB is a repressor of MMP-9 transcription in depolarized rat brain neurons. Mol. Cell. Neurosci. 2009, 40:98-110.
108. Sale A., Maya Vetencourt J.F., Medini P., Cenni M.C., Baroncelli L., et al. Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition. Nat. Neurosci. 2007, 10:679-681.
109. Salles F.J., Strickland S. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J. Neurosci. 2002, 22:2125-2134.
110. Samochowiec A., Grzywacz A., Kaczmarek L., Bienkowski P., Samochowiec J., Mierzejewski P., et al. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene in alcohol dependence: family and case control study. Brain Res. 2010, 1327:103-106.
111. Samson A.L., Medcalf R.L. Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 2006, 50:673-678.
112. Samson A.L., Nevin S.T., Croucher D., Niego B., Daniel P.B., Weiss T.W., et al. Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function. J. Neurochem. 2008, 107:1091-1101.
113. Sappino A.P., Madani R., Huarte J., Belin D., Kiss J.Z., Wohlwend A., et al. Extracellular proteolysis in the adult murine brain. J. Clin. Invest. 1993, 92:679-685.
114. Sbai O., Ferhat L., Bernard A., Gueye Y., Ould-Yahoui A., Thiolloy S., et al. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Mol. Cell. Neurosci. 2008, 39:549-568.
115. Seeds N.W., Basham M.E., Haffke S.P. Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14118-14123.
116. Shi Y., You J., Yuan Y., Zhang X., Li H., Hou G. Plasma BDNF and tPA are associated with late-onset geriatric depression. Psychiatry Clin. Neurosci. 2010, 64:249-254.
117. Shimizu C., Yoshida S., Shibata M., Kato K., Momota Y., Matsumoto K., et al. Characterization of recombinant and brain neuropsin, a plasticity-related serine protease. J. Biol. Chem. 1998, 273:11189-11196.
118. Shiosaka S., Ishikawa Y. Neuropsin-a possible modulator of synaptic plasticity. J. Chem. Neuroanat. 2011, 42:24-29.
119. Sodersten K., Palsson E., Ishima T., Funa K., Landen M., Kenji H., et al. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. J. Affect. Disord. 2014, 160:1-9.
120. Spolidoro M., Putignano E., Munafò C., Maffei L., Pizzorusso T. Inhibition of matrix metalloproteinases prevents the potentiation of nondeprived-eye responses after monocular deprivation in juvenile rats. Cereb. Cortex 2012, 22:725-734.
121. Stephan A., Mateos J.M., Kozlov S.V., Cinelli P., Kistler A.D., Hettwer S., et al. Neurotrypsin cleaves agrin locally at the synapse. FASEB J. 2008, 22:1861-1873.
122. Szepesi Z., Bijata M., Ruszczycki B., Kaczmarek L., Wlodarczyk J. Matrix metalloproteinases regulate the formation of dendritic spine head protrusions during chemically induced long-term potentiation. PLoS One 2013, 8:e63314.
123. Szepesi Z., Hosy E., Ruszczycki B., Bijata M., Pyskaty M., Bikbaev A., Heine M., Choquet D., Kaczmarek L., Wlodarczyk J. Synaptically released matrix metalloproteinase activity in control of structural plasticity and the cell surface distribution of GluA1-AMPA receptors. PLoS One 2014, 22:e98274.
124. Szklarczyk A., Kaczmarek L. Physiology of matrix MMPs and their tissue inhibitors in the brain. Biotechol. Intl. 2005, 17:15-18.
125. Szklarczyk A., Lapinska J., Rylski M., McKay R.D.G., Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 2002, 22:920-930.
126. Tamura H., Ishikawa Y., Hino N., Maeda M., Yoshida S., Kaku S., et al. Neuropsin is essential for early processes of memory acquisition and Schaffer collateral long-term potentiation in adult mouse hippocampus in vivo. J. Physiol. 2006, 570:541-551.
127. Tamura H., Kawata M., Hamaguchi S., Ishikawa Y., Shiosaka S. Processing of neuregulin-1 by neuropsin regulates GABAergic neuron to control neural plasticity of the mouse hippocampus. J. Neurosci. 2012, 32:12657-12672.
128. Tamura H., Ishikawa Y., Shiosaka S. Does extracellular proteolysis control mammalian cognition?. Rev. Neurosci. 2013, 24:365-374.
129. Taniguchi Y., Inoue N., Morita S., Nikaido Y., Nakashima T., Nagai N., et al. Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus. Cell Tissue Res. 2011, 343:303-317.
130. Tian L., Stefanidakis M., Ning L., Van Lint P., Nyman-Huttunen H., Libert C., et al. Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage. J. Cell Biol. 2007, 178:687-700.
131. Tidow H., Mattle D., Nissen P. Structural and biophysical characterisation of agrin laminin G3 domain constructs. Protein Eng. Des. Sel. 2011, 24:219-224.
132. Tsirka S.E., Gualandris A., Amaral D.G., Strickland S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995, 377:340-344.
133. Wang D., Fawcett J. The perineuronal net and the control of CNS plasticity. Cell Tissue Res. 2012, 349:147-160.
134. Wang X.-B., Bozdagi O., Nikitczuk J.S., Zhai Z.W., Zhou Q., Huntley G.W. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19519-19524.
135. Wiediger R.V., Wright J.W. Influence of dorsal hippocampal lesions and MMP inhibitors on spontaneous recovery following a habituation/classical conditioning head-shake task. Neurobiol. Learn. Mem. 2009, 92:504-511.
136. Wiera G., Wójtowicz T., Lebida K., Piotrowska A., Drulis-Fajdasz D., Gomułkiewicz A., et al. Long term potentiation affects intracellular metalloproteinases activity in the mossy fiber-CA3 pathway. Mol. Cell. Neurosci. 2012, 50:147-159.
137. Wiera G., Wozniak G., Bajor M., Kaczmarek L., Mozrzymas J.W. Maintenance of long-term potentiation in hippocampal mossy fiber-CA3 pathway requires fine-tuned MMP-9 proteolytic activity. Hippocampus 2013, 23:529-543.
138. Wilczynski G.M., Konopacki F.A., Wilczek E., Lasiecka Z., Gorlewicz A., Michaluk P., et al. Important role of matrix metalloproteinase 9 in epileptogenesis. J. Cell Biol. 2008, 180:1021-1035.
139. Wlodarczyk J., Mukhina I., Kaczmarek L., Dityatev A. Extracellular matrix molecules, their receptors, and secreted proteases in synaptic plasticity. Dev. Neurobiol. 2011, 71:1040-1053.
140. Wójtowicz T., Mozrzymas J.W. Late phase of long-term potentiation in the mossy fiber-CA3 hippocampal pathway is critically dependent on metalloproteinases activity. Hippocampus 2010, 20:917-921.
141. Wolfer D.P., Lang R., Cinelli P., Madani R., Sonderegger P. Multiple roles of neurotrypsin in tissue morphogenesis and nervous system development suggested by the mRNA expression pattern. Mol. Cell. Neurosci. 2001, 18:407-433.
142. Wright J.W., Meighan S.E., Murphy E.S., Holtfreter K.L., Davis C.J., Olson M.L., et al. Habituation of the head-shake response induces changes in brain matrix metalloproteinases-3 (MMP-3) and -9. Behav. Brain Res. 2006, 174:78-85.
143. Wright J.W., Brown T.E., Harding J.W. Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory. Neural Plast. 2007, 2007:1-8.
144. Wright J.W., Meighan P.C., Brown T.E., Wiediger R.V., Sorg B.A., Harding J.W. Habituation-induced neural plasticity in the hippocampus and prefrontal cortex mediated by MMP-3. Behav. Brain Res. 2009, 203:27-34.
145. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 1968, 243:1523-1535.
146. Yamamori H., Hashimoto R., Ishima T., Kishi F., Yasuda Y., Ohi K., et al. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine. Neurosci. Lett. 2013, 556:37-41.
147. Yepes M., Lawrence D.A. Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system. Thromb. Haemost. 2004, 91:457-464.
148. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 2005, 6:931-944.
149. Yoshida T., Ishikawa M., Niitsu T., Nakazato M., Watanabe H., Shiraishi T., et al. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One 2012, 7:e42676.
150. Yuan W., Matthews R.T., Sandy J.D., Gottschall P.E. Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience 2002, 114:1091-1101.
151. Zagulska-Szymczak S., Filipkowski R.K., Kaczmarek L. Kainate-induced genes in the hippocampus: lessons from expression patterns. Neurochem. Int. 2001, 38:485-501.
152. Zhuo M., Holtzman D.M., Li Y., Osaka H., DeMaro J., Jacquin M., et al. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J. Neurosci. 2000, 20:542-549.